Abstract
The bioeffectivity of the therapeutically stable modification A of chloramphenicol palmitate is essentially less than that of the metastable modification B. The literature data indicate that the transformation of modification B to modification A is always monotropic. However, by means of cyclic heat treatment, the stable, inactive modification A has now been successfully transformed to the ‘metastable’, but pharmaceutically effective modification B. For identification and determination of the inactive polymorph A (as impurity) in the active polymorph B, DSC affords rapid and well-reproducible results on small samples. This method may be recommended for inclusion in pharmacopoeias.
References
A Burger, Sci. Pharm., 45 (1977) 269.
A. Burger and R. Ramberger, Mikrochim. Acta II., (1979) 259.
M. Otsuka and N. Kaneniwa, J. Pharm. Sci., 75 (1986) 5.
M. M. De Villiers, J. G. van der Watt, A. P. Lötter, Drug Develop. Ind. Pharm., 17 (1991) 1295.
The United States Pharmacopoeia (USP 23) Rockville 1995, p. 338.
British Pharmacopoeia II. London 1993, p. 823.
Pharmacopoeia Hungarica VII. Medicina, 1986.
V. Ferioli, G. Gamberini, R. Cameroni, Farmaco Ed. Prot., 29 (1974) 309.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Csakurda-Harmathy, Z., Thege, I.K. Transformation of chloramphenicol palmitate from therapeutically inactive polymorph A to active polymorph B. Journal of Thermal Analysis 50, 867–871 (1997). https://doi.org/10.1007/BF01979216
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01979216